AzTrials
AzTrials

Vaginal Laceration During DeliveryLAC-VAG-2025NCT07124676

Prospective Study Comparing Two Classification Systems for Second-degree Vaginal Tears During Spontaneous Childbirth to Assess Their Ability to Predict Postpartum Complications.

An observational study of Vaginal Laceration During Delivery, run by University of Campania Luigi Vanvitelli at 1 site in Italy.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to learn whether different classification systems for second-degree perineal tears can predict postpartum complications in women undergoing spontaneous vaginal childbirth. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Vaginal Laceration During Delivery
How many people
482 participants
Where
1 siteItaly
Study dates
4 Nov 2025to 1 Oct 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: Women giving birth, who experience a spontaneous vaginal delivery resulting in a spontaneous second-degree perineal tear. Participants are recruited consecutively from the hospital's maternity ward during the study period.

Who may be able to join

  • Female at birth
  • Age ≥ 18 years
  • Spontaneous vaginal delivery
  • Presence of a spontaneous second-degree perineal tear confirmed on -postpartum examination
  • Ability and willingness to provide informed consent

Who cannot join

  • Obstetric or medical conditions preventing spontaneous vaginal delivery
  • Inability to understand study procedures or complete follow-up assessments

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Marco La Verde, MD, researcher contact

+393389412266

marco.laverde@unicampania.it

Italy1 site, 1 recruiting
  • Universita degli studi della Campania "Luigi Vanvitelli" - dipartimento della donna, bambino e chirurgia generale e specialistica,

    Naples, Italy, 80138

    Marco La Verde, MD, researcher, +393389412266, marco.laverde@unicampania.it

    Recruiting

Other trials in Italy

About this study

Official title: Prospective Observational Study Comparing Two Classifications of Second-degree Perineal Tears in Spontaneous Vaginal Births, to Evaluate Their Correlation With Postpartum Clinical Outcomes.

The goal of this observational study is to learn whether different classification systems for second-degree perineal tears can predict postpartum complications in women undergoing spontaneous vaginal childbirth. The main questions it aims to answer are:

Does the Scandinavian classification better predict postpartum complications such as hemoglobin drop, perineal pain, occult muscle injury, and sexual dysfunction? Does the De Simone classification better correlate with these same postpartum outcomes?

Read more

Researchers will compare the Scandinavian classification and the De Simone classification to see which system more accurately predicts clinically relevant postpartum complications.

Participants will:

Undergo standard clinical assessment after spontaneous vaginal delivery with a second-degree perineal tear Have their perineal tear classified using both the Scandinavian and De Simone systems Receive routine postpartum evaluation, including hemoglobin measurement, pain assessment (VAS), and perineal ultrasound Complete follow-up assessment of sexual function using the Female Sexual Function Index (FSFI)

Read the detailed description

Second-degree perineal tears are heterogeneous injuries involving the perineal muscles without anal sphincter involvement, and their anatomical variability may influence postpartum outcomes. Current standard classifications do not provide detailed subclassification, limiting risk stratification.

This prospective, single-center observational study evaluates the prognostic performance of two detailed classification systems: the Scandinavian classification (based on the extent of the perineal body) and the De Simone classification (based on vaginal extension and muscle involvement).

Participants are consecutively enrolled following spontaneous vaginal delivery with second-degree tears. Classification is performed during routine postpartum examination by trained clinicians using both systems, with independent assessment to minimize misclassification.

Data are collected prospectively and managed in a secure electronic database with predefined validation and consistency checks. Source data verification is performed against clinical records, and variables are standardized through a predefined data dictionary.

The statistical approach includes multivariable modeling to assess the association between tear subtypes and clinical outcomes, adjusting for relevant confounders. Model performance will be evaluated using standard calibration and discrimination metrics, with predefined strategies for handling missing data.

The study is non-interventional and conducted in accordance with Good Clinical Practice.

Keywords
vaginal laceration, delivery

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07124676
Study groupRoleWhat they receive
Women with spontaneous second-degree perineal tearsParticipants are women who have a spontaneous vaginal birth and sustain a spontaneous second-degree perineal tear. Each tear is classified according to both the Scandinavian (Macedo et al., 2022) and De Simone systems during routine postpartum examination. No experimental intervention is performed; outcomes are collected through clinical records, postpartum examination, ultrasound, and validated questionnaires (FSFI).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. hemoglobin reduction

    significant hemoglobin reduction (>2 g/dL from pre- to post-delivery)

    Measured: within 48 hours postpartum

  2. moderate-to-severe perineal pain

    Visual Analog Scale (VAS) ≥ 5; (VAS; range 0-10, where 0 = no pain and 10 = worst imaginable pain); moderate-to-severe pain defined as VAS ≥ 5

    Measured: within 48 hours postpartum

  3. pathological Female Sexual Function Index (FSFI) total score

    FSFI total score modification after vaginal laceration Female Sexual Function Index (FSFI total score; range 2-36, where lower scores indicate worse sexual function and higher scores indicate better function), evaluated as change from baseline

    Measured: within 48 hours after the delivery

Secondary outcomes (1)
  1. occult perineal or vaginal muscle lesions

    occult perineal or vaginal muscle lesions on postpartum perineal ultrasound;

    Measured: within 7 days postpartum for ultrasound assessment; at 3 months postpartum for FSFI evaluation.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Aug 2025
  2. Study start4 Nov 2025
  3. Primary completion1 Nov 2026 (estimated)
  4. Study completion1 Oct 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
482 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07124676
Sponsor's protocol ID
0016346/i
Acronym
LAC-VAG-2025
Status last verified
Apr 2026
First submitted
9 Aug 2025
Last updated
28 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data (IPD) will not be shared due to institutional policies and ethical considerations regarding the protection of participants' privacy.

Publications

  • Macedo MD, Ellstrom Engh M, Siafarikas F. Detailed classification of second-degree perineal tears in the delivery ward: an inter-rater agreement study. Acta Obstet Gynecol Scand. 2022 Aug;101(8):880-888. doi: 10.1111/aogs.14369. Epub 2022 May 11.

    PubMed 35546433

Questions about this trial

What is this clinical trial studying?

An observational study of Vaginal Laceration During Delivery, run by University of Campania Luigi Vanvitelli at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 28 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Marco La Verde, MD, researcher (+393389412266, marco.laverde@unicampania.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

hemoglobin reduction (time frame: within 48 hours postpartum). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07124676, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in